Achieve Life Sciences stock forecast
Achieve Life Sciences (SP4P) Stock Forecast & Price Target
SP4P Analyst Ratings
SP4P Stock 12 Month Forecast
Average Price Target
€12.05▲(125.27% Upside)Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Justin Walsh | JonesTrading | €9.07 | buy | 69.56%Upside | Reiterated | 11/12/26 | ||
| Brandon Folkes | H.C. Wainwright | €10.89 | buy | 103.47%Upside | Reiterated | 11/11/26 | ||
| Jason McCarthy | Maxim Group | €9.07 | buy | 69.56%Upside | Reiterated | 11/11/26 | ||
| Gary Nachman | Canaccord Genuity | €11.79 | buy | 120.43%Upside | Reiterated | 11/10/26 | ||
| Maxwell Skor | Morgan Stanley | €11.79 | buy | 120.43%Upside | Reiterated | 10/21/26 | ||
| Patrick Dolezal | LifeSci Capital | €15.42 | buy | 188.25%Upside | Reiterated | 10/21/26 | ||
| James Condulis | Stifel Nicolaus | €16.33 | buy | 205.21%Upside | Initiated | 09/30/26 | ||
| Ryan Deschner | Raymond James | €18.14 | buy | 239.12%Upside | Initiated | 06/26/26 | ||
| Mark Smith | Lake Street | €9.98 | buy | 86.52%Upside | Reiterated | 05/13/26 | ||
| Jason Butler | Citizens JMP | €17.24 | buy | 222.17%Upside | Initiated | 11/25/25 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Justin WalshJonesTrading | BuyReiterated€9.07 | 11/12/26 | 69.56%Upside | ||
| Brandon FolkesH.C. Wainwright | BuyReiterated€10.89 | 11/11/26 | 103.47%Upside | ||
| Jason McCarthyMaxim Group | BuyReiterated€9.07 | 11/11/26 | 69.56%Upside | ||
| Gary NachmanCanaccord Genuity | BuyReiterated€11.79 | 11/10/26 | 120.43%Upside | ||
| Maxwell SkorMorgan Stanley | BuyReiterated€11.79 | 10/21/26 | 120.43%Upside | ||
| Patrick DolezalLifeSci Capital | BuyReiterated€15.42 | 10/21/26 | 188.25%Upside | ||
| James CondulisStifel Nicolaus | BuyInitiated€16.33 | 09/30/26 | 205.21%Upside | ||
| Ryan DeschnerRaymond James | BuyInitiated€18.14 | 06/26/26 | 239.12%Upside | ||
| Mark SmithLake Street | BuyReiterated€9.98 | 05/13/26 | 86.52%Upside | ||
| Jason ButlerCitizens JMP | BuyInitiated€17.24 | 11/25/25 | 222.17%Upside |
Best Analysts Covering Achieve Life Sciences
Copying Jason McCarthy's trades and holding each position for 3 Months would result in 63.64% of your transactions generating a profit, with an average return of +29.51% per trade.
Copying Jason McCarthy's trades and holding each position for 1 Year would result in 81.82% of your transactions generating a profit, with an average return of +66.79% per trade.
Copying Justin Walsh's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +69.32% per trade.
SP4P Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 10 | 11 | 9 | 13 | 10 |
| Buy | 0 | 1 | 1 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 10 | 12 | 10 | 14 | 10 |
In the current month, SP4P has received 10 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. SP4P average Analyst price target in the past 3 months is 12.05.
SP4P Financial Forecast
SP4P Earnings Forecast
Next quarter’s earnings estimate for SP4P is -EUR 0.18 with a range of -EUR 0.23 to -EUR 0.09. The previous quarter’s EPS was -EUR 0.10. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
SP4P Sales Forecast
Next quarter’s sales forecast for SP4P is EUR 0 with a range of EUR 0 to EUR 0. The previous quarter’s sales results were EUR 0. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

